sar302503
Showing 1 - 8 of 8
Hematopoietic Tumor Trial in United States (SAR302503)
Completed
- Hematopoietic Neoplasm
- SAR302503
-
San Francisco, California
- +3 more
Feb 17, 2016
Hematopoietic Tumor Trial in Worldwide (SAR302503)
Completed
- Hematopoietic Neoplasm
- SAR302503
-
Scottsdale, Arizona
- +34 more
Feb 17, 2016
Hematopoietic Tumor Trial in Worldwide (SAR302503)
Completed
- Hematopoietic Neoplasm
- SAR302503
-
Phoenix, Arizona
- +41 more
Feb 17, 2016
Renal Impairment Trial in Orlando, St. Paul, Knoxville (SAR302503)
Completed
- Renal Impairment
- SAR302503
-
Orlando, Florida
- +2 more
May 12, 2015
Hematopoietic Tumor Trial in Worldwide (SAR302503, Placebo)
Completed
- Hematopoietic Neoplasm
- SAR302503
- Placebo
-
Scottsdale, Arizona
- +100 more
Dec 8, 2015
Myelofibrosis Trial in Japan (SAR302503)
Completed
- Myelofibrosis
- SAR302503
-
Akita-Shi, Japan
- +6 more
Sep 19, 2014
Hepatic Impairment Trial in Miami, Orlando, Knoxville (SAR302503)
Completed
- Hepatic Impairment
- SAR302503
-
Miami, Florida
- +2 more
Aug 28, 2013
Solid Tumor Trial in Augusta, Detroit, Philadelphia (SAR302503, omeprazol, metoprolol)
Completed
- Solid Tumor
- SAR302503
- +3 more
-
Augusta, Georgia
- +2 more
Mar 21, 2013